ventyx biosciences news

Ventyx Biosciences, Sanofi

Ventyx stock climbs 8% on $27M Sanofi investment

Ventyx (VTYX) stock jumped 8% on news that Sanofi (SNY) has made a $27M strategic investment in the company at an as-converted price of $3.8243 per common share. Read more here.

Business Insider · 12h

Ventyx Biosciences: Cautious Optimism Amidst Sanofi’s Strategic Investment and Upcoming Clinical Trials

H.C. Wainwright analyst Emily Bodnar maintained a Hold rating on Ventyx Biosciences (VTYX – Research Report) today and set a price target

MarketWatch · 15h

Ventyx Biosciences Shares Rise Premarket on Sanofi Investment

Shares of Ventyx Biosciences rose more than 20% in premarket trading after the clinical-stage biopharmaceutical company said it would receive a $27 million from France's Sanofi.

GlobalData on MSN7h

Sanofi gains exclusivity rights to Ventyx’s CNS-penetrant drug in $27m deal

Under the terms of the agreement, Sanofi will gain an exclusive right to first negotiation for the CNS-penetrant, VTX3232.

FierceBiotech13h

Sanofi scoops negotiation rights to Ventyx obesity, Parkinson’s candidate for $27M

The Sanofi equity investment means the Big Pharma will receive exclusive rights of first negotiation surrounding VTX3232, an ...

13hon MSN

Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences

Sanofi SA (NASDAQ:SNY) agreed to make a $27 million strategic investment in Ventyx Biosciences Inc (NASDAQ:VTYX). “We look ...

bovnews2d

Ventyx Biosciences Inc (VTYX) Stock Dive: The Hidden Causes Revealed

Ventyx Biosciences Inc (VTYX) stock saw a decline, ending the day at $2.3 which represents a decrease of $-0.07 or -2.95% from the prior close of $2.37. The stock opened at $2.34 and touched a low of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics